U.S. markets closed

NOV Inc. (NOV)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
15.43-0.64 (-3.98%)
At close: 04:00PM EST
15.32 -0.11 (-0.71%)
After hours: 05:43PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close16.07
Bid15.00 x 900
Ask15.43 x 1200
Day's Range15.35 - 15.99
52 Week Range11.46 - 18.02
Avg. Volume3,878,683
Market Cap6.028B
Beta (5Y Monthly)2.23
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.20 (1.30%)
Ex-Dividend DateDec 02, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for NOV

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NOV Inc.
    Technical Assessment: Bullish in the Intermediate-TermThe S&P 500 approached a key support area on Monday and bounced quite nicely. The 21-week exponential (EMA) sits at 4,570, and has provided solid support going back to early 2020. Channel support comes in at 4,550, while the middle weekly Bollinger Band lies at 4,578. The low on the "500" yesterday was 4,582. Lower supports come in at 4,445 from the 10-month EMA, and at 4,410 from the 200-day average.
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
  • Moody's

    NOV Inc. -- Moody's announces completion of a periodic review of ratings of NOV Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of NOV Inc.Global Credit Research - 21 Jan 2022New York, January 21, 2022 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of NOV Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review discussion held on 19 January 2022 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion.This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.


    Nepsis, Inc. Buys Qualcomm Inc, NOV Inc, Cigna Corp, Sells Ventas Inc, Fulgent Genetics Inc, ...

    Investment company Nepsis, Inc. (Current Portfolio) buys Qualcomm Inc, NOV Inc, Cigna Corp, F5 Inc, General Mills Inc, sells Ventas Inc, Fulgent Genetics Inc, American International Group Inc, Freshworks Inc, Freshworks Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Nepsis, Inc..


    Syntax Etf Trust Buys Perrigo Co PLC, Unum Group, GameStop Corp, Sells Ligand Pharmaceuticals ...

    Investment company Syntax Etf Trust (Current Portfolio) buys Perrigo Co PLC, Unum Group, GameStop Corp, Performance Food Group Co, NOV Inc, sells Ligand Pharmaceuticals Inc, CMC Materials Inc, Cinemark Holdings Inc, Bio-Techne Corp, Treehouse Foods Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Syntax Etf Trust.